With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
In this video, Sarah DiGeronimo, NP, and Sydney Smith, PharmD, both from Dana-Farber Cancer Institute, Boston, Massachusetts, discuss tips for the management of common side effects resulting from…
NEW YORK (Reuters Health) – For women with thyroid cancer treated with radioiodine-131, subsequent pregnancy is safe without adverse outcomes for the offspring. That’s according to a report…
NEW YORK (Reuters Health) – The morbidity of extensive axillary lymph node dissection can be avoided without jeopardizing survival for some breast cancer patients with positive sentinel lymph…
NEW YORK (Reuters Health) – The combination of fibrate and statin therapy is a safe and efficacious treatment option for women with multiple lipid abnormalities, a multicenter team…
NEW YORK (Reuters Health) – An interval of no more than 14 days between ultrasonograms in monochorionic twins appears to increase detection of twin-to-twin transfusion syndrome (TTTS), researchers…
NEW YORK (Reuters Health) – For women with low-risk gestational trophoblastic neoplasia, dactinomycin given every 2 weeks had a higher complete response rate than weekly methotrexate in a…
NEW YORK (Reuters Health) – Women with polycystic ovary syndrome have increased levels of LDL-cholesterol and non-HDL-cholesterol, as well as more widely recognized alterations in triglycerides and HDL…
NEW YORK (Reuters Health) – Neither injectable nor oral contraceptives have a meaningful effect on glucose or insulin levels, researchers report in the January 2011 Obstetrics & Gynecology.…
NEW YORK (Reuters Health) – The response rate to high-dose pulsed intravenous glucocorticoid therapy is about 80% for patients with active Graves’ orbitopathy, German clinicians report. However, they…
NEW YORK (Reuters Health) – Intravenous immunoglobulin (IVIG) is not helpful in the treatment of women with unexplained recurrent miscarriage and, for now, should not be used outside…
NEW YORK (Reuters Health) – In a small study of pregnant women with type 1 diabetes, use of a closed-loop insulin delivery system (also known as the artificial…
